Literature DB >> 1127099

Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.

K O'Malley, M Velasco, J Wells, J L McNay.   

Abstract

A study was made of the possible mechanism(s) underlying minoxidil-induced increase in plasma renin activity (PRA). 10 patients with essential hypertension were treated with minoxidil and subsequently with a combination of minoxidil plus propranolol. Minoxidil lowered mean arterial pressure 31.6 plus or minus 3.3 mm Hg, mean plus or minus SEM. There was an associated increase in both PRA, 6.26 plus or minus 2.43 NG/ML/H, and heart rate, 21.4 plus or minus 2.7 beats/min. The changes in PRA and heart rate were positively correlated, r, 0.79. Addition of propranolol reduced mean arterial pressure by a further 10.1 plus or minus 1.5 mm Hg and returned heart rate to control levels. Propranolol reduced PRA significantly but not to control levels. Control PRA positively correlated with PRA on minoxidil, r, 0.97, and with PRA on minoxidil plus propranolol, r, 0.98. We conclude that control PRA is a major determinant of change in PRA with minoxidil. Minoxidil increased PRA by at least two mechanisms: (a) an adrenergic mechanism closely related to change in heart rate and blocked by propranolol, and (b) a mechanism(s) not sensitive to propranolol and possibly related to decrease in renal perfusion pressure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127099      PMCID: PMC301741          DOI: 10.1172/JCI107926

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  A study of the mechanism of the hemodynamic effects of hydralazine in man.

Authors:  B ABLAD
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

3.  Effect of methyldopa on plasma renin activity in man.

Authors:  S Mohammed; A F Fasola; P J Privitera; R J Lipicky; B L Martz; T E Gaffney
Journal:  Circ Res       Date:  1969-11       Impact factor: 17.367

4.  Effects of catecholamines and renal nerve stimulation on renin release in the nonfiltering kidney.

Authors:  J A Johnson; J O Davis; R T Witty
Journal:  Circ Res       Date:  1971-12       Impact factor: 17.367

5.  Renin release in patients with benign essential hypertension.

Authors:  Y Kaneko; T Ikeda; T Takeda; G Inoue; H Tagawa; H Ueda
Journal:  Circulation       Date:  1968-08       Impact factor: 29.690

6.  Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs.

Authors:  A J Vander
Journal:  Am J Physiol       Date:  1965-09

7.  Renin, norepinephrine, and epinephrine responses to graded exercise.

Authors:  T A Kotchen; L H Hartley; T W Rice; E H Mougey; L G Jones; J W Mason
Journal:  J Appl Physiol       Date:  1971-08       Impact factor: 3.531

8.  The effect of diazoxide on catecholamines.

Authors:  Z Zarday; J Viktora; F Wolff
Journal:  Metabolism       Date:  1966-03       Impact factor: 8.694

9.  Effect of diazoxide on plasma renin activity in hypertensive patients.

Authors:  O Küchel; L M Fishman; G W Liddle; A Michelakis
Journal:  Ann Intern Med       Date:  1967-10       Impact factor: 25.391

10.  Role of the sympathetic nervous system in regulating renin and aldosterone production in man.

Authors:  R D Gordon; O Küchel; G W Liddle; D P Island
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  15 in total

1.  Need for beta-blockade in hypertension reduced with long-term minoxidil.

Authors:  H R Brunner; P Jaeger; R K Ferguson; E Jequier; G Turini; H Gavras
Journal:  Br Med J       Date:  1978-08-05

Review 2.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

3.  Effect of beta adrenergic blockade on renin response to renal nerve stimulation.

Authors:  M S Taher; L G McLain; K M McDonald; R W Schrier; L K Gilbert; G A Aisenbrey; A L McCool
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

Review 4.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

5.  Acute effects of a new vasodilator, Ro 12-4713, on blood pressure, plasma Renin activity, Aldosterone and Catecholamine levels, and renal function in hypertensive and normal subjects.

Authors:  M Grimm; P Weidmann; A Meier; W H Ziegler; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.

Authors:  K Aoki; K Sato; Y Kawaguchi; M Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Minoxidil and captopril in severe hypertension.

Authors:  P Greminger; E Foerster; H Vetter; P Baumgart; W Vetter
Journal:  Klin Wochenschr       Date:  1986-04-01

8.  Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.

Authors:  M G Bianchetti; P Weidmann; K Boehringer; L Link; H Schiffl; C Beretta-Piccoli; J P Colombo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.

Authors:  A Meier; P Weidmann; W H Ziegler
Journal:  Klin Wochenschr       Date:  1981-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.